Introduction
One of the most challenging management tasks in a pediatric intensive care unit (PICU) is providing optimum sedation in patients on mechanical ventilation. Sedation is thought to be essential in mechanically ventilated patients to maintain patient safety and comfort. Although sedation is a crucial treatment, excessive sedation may adversely affect patient outcomes.
1 Excessive sedation prolongs mechanical ventilation, ICU length of stay (LOS), and hospital LOS. 2 Longer mechanical ventilation can predispose to further complications, such as ventilator associated pneumonia (VAP), opioid tolerance, and iatrogenic withdrawal. On the other hand, inadequate sedation and pain control can cause patient discomfort, agitation, and possibly self-extubation.
The assessment of sedation and adjustment of medications are critical for mechanically ventilated children. Several sedation scoring scales have been described in pediatrics, such as the COMFORTscale, Ramsayscale, the sedation-agitation scale, motor activity assessment scale, the state behavioral scale, and face, leg, activity, cry, consolability (FLACC). 4, 5 The COMFORT scale has been validated in pediatrics and is well structured. However, the COMFORT scale has physiologic parameters that are influenced by causes other than the level of sedation. This was subsequently modified into the COMFORT-B scale which uses the behavior of the patient from direct observation. 6 The COMFORT-B scale is well validated in pediatric and neonatal patients. 6 and detects treatment-related changes in pain or distress intensity. Therefore, the COMFORT-B scale can effectively assess and guide sedation in pediatric patients who require mechanical ventilation.
7
There is a limited amount of data on protocol-directed sedation in pediatric patients. 8 This study compares sedation level assessments by the COMFORT-B scale with a medication adjustment protocol to usual care to assess the reduction of mechanical ventilation days.
Materials and Methods

Design
This study was a nonrandomized prospective cohort study compared with a historical control. The study was approved by the institutional board review and Thai Clinical Trials Registry (TCTR; TCTR 20181208001). The sedation levels of the patients in the intervention group were assessed by the COMFORT-B scale and the sedative medications were adjusted according to the newly developed sedation protocol. The control group was assessed and the sedative medications were adjusted by bedside nurses and attending physicians based on clinical judgment (►Fig. 1). The primary outcome of this study was to compare the mechanical ventilation days between the two groups. The secondary outcome was to compare LOS (days) in PICU.
Study Location and Period
This study was conducted in a tertiary care level PICU at a referral center in southern Thailand. The study periods in the historical group and intervention group were from November 2014 to August 2015 and from November 2015 to August 2016, respectively. Data collection was performed in the same seasonal period for both groups to decrease bias.
Patients
The inclusion criteria included patients, 1 month to 15 years old, who were admitted to the PICU, intubated, and received sedative medication for at least 48 hours. The exclusion criteria for this study included patients with neurological disease because the level of sedation cannot be assessed by the COMFORT-B scale, patients who received neuromuscular blockade, and patients who needed a very deep sedation level for treatment as in cases of pulmonary hypertensive crisis.
Sample Size Calculation
From a previous study, assessment using the COMFORT scale could decrease the number of ventilation days by 1.5 days. 9 We used the two independent means test (twotailed test) and defined the difference to be equal to 2 days. From the calculation, the number of participants in each group was 53. To compensate for incomplete data, the number of participants was increased by 10%. The total number of participants in each group was 58. In the historical control group, the number of patients admitted to the PICU and eligible for the study was 70. Therefore, computerized random sampling was done to select the patients for the study.
Intervention and Study Protocol
The intervention in this study consisted of two main parts. First was the sedation level assessment by COMFORT-B scale and second was the sedative medication adjustment protocol. A newly developed standard and stepwise-approach protocol was used to guide and direct the adjustment of sedative medications. The sedative medication adjustment protocol constituted in three parts: a basic approach, an increasing scheme, and a decreasing scheme (►Figs. 2-4).
After formal consent by the parents or caregivers, the COMFORT-B scale was used in the intervention group to assess the sedation level every 12 hours by a pediatric resident. COMFORT-B levels of 5 to 10 were defined as over sedation, 11 to 22 as optimum sedation, and 23 to 30 as inadequate sedation as previously described. 10 The sedative medications were adjusted according to the protocol. In our protocol, continuous infusion of an opioid was used as the initial medication. Morphine was the first line medication. However, fentanyl was used instead of morphine in neonates and patients who had liver dysfunction. If the patient had inadequate sedation, the medications were escalated as per the increasing scheme. On the other hand, in patients who were over sedated the medications were weaned per the decreasing scheme. In the historical control group, the sedative medications were adjusted according to the nursing assessment and attending physicians only in the morning rounds. The sedation medications were stopped at least 6 hours before extubation in both groups according to the weaning and extubation protocol in the PICU.
Data Collection
The data of all participants in both groups were extracted from the medical records. Baseline characteristics included age, underlying diseases, other medications (e.g., inotropic drugs and the sedative medications that included continuous infusion form, intravenous [IV] intermittent form, and oral form). Pediatric risk of mortality III (PRISM III) scores were recorded for severity of illness. The dosage of sedative medication and analgesia are presented as mg/kg/day for midazolam, morphine, and chloral hydrate and mcg/kg/day for fentanyl. The outcomes were duration of mechanical ventilation (days), self-extubation rate, LOS (days) in PICU, hospital LOS (days), and 28-day mortality. COMFORT-B Scale Use in Mechanically Ventilated Children Saelim et al. 159
Statistical Analysis
Mann-Whitney rank sum test was used for continuous data and Chi-square analysis or Fisher's exact test or Pearson's Chisquare test for the discrete data. Data were presented as mean AE standard deviation (SD) and median with interquartile range (IQR). Clinical significance was determined by p < 0.05. Spearman's rank correlation coefficient was used to evaluate the correlation of PRISM III and primary outcome. Multiple logistic regression was applied to determine the odds of the primary outcome that depended on covariate variables.
Results
Patient Characteristics
The study population included 116 participants, 58 in each group. The baseline characteristics are described in ►Table 1.
The overall baseline characteristics, that included age, sex, underlying diseases, and surgical patients, were the same in the two groups. However, the PRISM III scores were higher in the intervention group 
Primary Outcome and Secondary Outcome
The mean ventilator days in the intervention groups were 4.5 days (IQR: 2.2-10.5) which was not significantly different from the control group of 5.0 days (IQR: 3.0-8.8). The PICU LOS and hospital LOS were the same between the two groups (►Table 2). There were no significant differences of self-extubation events and 28-day PICU mortality rates between the two groups.
Subgroup Analysis
Since the nature of the study was nonrandomized prospective cohort study that compared the results with a historical control group, the intervention group had higher PRISM III scores. Spearman's rank correlation coefficient was used to evaluate the correlation of the PRISM III scores and ventilator days. The ρ (Rho) was 0.18 which meant a poor correlation between the PRISM III score and ventilator days. Multiple logistic regression was used to evaluate the factors that possibly affected ventilator days. The median number of ventilator days of all participants was 5 days. Therefore, an outcome of ! 5 ventilator days was used in multiple logistic regression analysis and the results are given in ►Table 3. The only factors that had an effect on ventilator days were medical or surgical conditions. The medical patients had an adjusted odds ratio of prolonged mechanical ventilation (! 5 days) equal to 3.39 (range: 1.53-7.49), p < 0.05. So, the subgroup analysis was conducted to determine the effect of intervention. In patients with medical illness, the PRISM III scores were significantly higher in the intervention group but the ventilator days were not significantly different. In patients with postoperative conditions, the PRISM III scores and ventilator days were not significantly different between the two groups (►Table 4). 
Medication Usage
In terms of medication usage, the number of patients that received each medication and the cumulative doses during the hospital stay were recorded. The numbers of patients who received sedative medication (►Fig. 5) and the cumulative dosages (►Table 5) were not significantly different between the intervention and control groups with the exception of chloral hydrate. 
Discussion
From our study, protocolized sedation utilizing the COM-FORT-B scale did not significantly reduce mechanical ventilation days compared with usual care. This finding was also seen in recent studies on sedation protocols in mechanically ventilated patients. [11] [12] [13] There were multiple factors that affected the duration of mechanical ventilation, especially the severity of illness. In our study, the intervention group had higher PRISM III scores which reflected sicker participants. However, the PRISM III scores were poorly correlated with ventilator days in the secondary analysis. The frequency of assessment also possibly played a role in medication adjustment. In our study, the assessment was done routinely every 12 hours and when necessary. Most participants in the intervention group had adequate sedation and rarely needed adjustment. The frequency of assessment was also the same in the historical control group. Multiple logistic regression analysis showed that the only factor that contributed to ventilator days was medical illness. Medical patients had longer duration of mechanical ventilation and LOS in PICU due to the complexities and treatments of the diseases. Consequently, the application of the same optimum goal of sedation level may not be suitable in all patients. The sedation level may need adjustment according to the phase of illness and the individual patient. The other possible cause of no significant reduction in duration of mechanical ventilation was the small number of patients. Furthermore, the previous study, showing that adjusting sedation medications by using the COMFORT scale could decrease ventilator days by 1.5 days, 9 did not describe how to adjust the medications.
This study also explored the rate of self-extubation and the total amount of sedative medication usage as a secondary outcome in the PICU. However, the number of self-extubation episodes was too low to compare between the two groups. There was no significant increase in the use of fentanyl and morphine since an opioid is the first line medication in our protocol. A significant reduction was observed in the number of patients in the intervention group who received chloral hydrate and in the total amounts of this medication after using the protocol, since chloral hydrate was used as an adjunctive medication. According to the treatment protocol, the management guideline and treatment protocols varied which depended on the center. [14] [15] [16] We developed a well-structured design for treatment that consisted of a basic scheme, a decreasing scheme, and an increasing scheme. So, in terms of generalizability, this protocol can be applied and may have benefit in a developing unit. In our historical controlled group, the sedation levels were done by experienced nurses and the results between the two groups were not statistically different. In addition, we assumed that in a stepwise approach to decrease or increase medication, the rate of iatrogenic withdrawal symptoms would decrease.
17
To our knowledge, this is the first study to conduct an assessment of the COMFORT-B scale with a sedative medication adjustment protocol. Moreover, in our study, the COM-FORT-B assessor was a pediatric resident, who was well trained and had good knowledge of the interpretation of the COMFORT-B scale. However, a limitation is the prospective cohort study design compared with a historical control. Furthermore, our study was a single unit study with a small number of patients and some data were not available, especially iatrogenic withdrawal symptoms.
